Food Allergy in the Brain (FAB)

Food Allergy in the Brain: Investigating the Impact of Food Allergy on Children's Mental Health and Cognition, and the Associated Neurobiological Mechanisms

Preventing food allergic reactions predominantly relies on allergen avoidance and managing this daily causes high anxiety in some patients, while having an allergic reaction can cause a post-traumatic stress disorder-like syndrome in children. The underlying mechanisms of these psychological changes are poorly understood, but one potential mechanism may be post-natal hippocampal neurogenesis (HN). HN is the production of new neurons from stem cells in the hippocampus which is one of the brain centres for memory and mood regulation. HN has been associated with cognitive function and some psychiatric disorders. Importantly, it can be influenced by both internal (bloodstream) and external (exercise, diet, etc.) factors. This study will explore the link between food allergy and children's mental health and cognition, and to determine whether this is linked to changes in HN.

Study Overview

• Status: Recruiting
• Conditions: Anxiety; Cognitive Symptom; Food Allergy; Food Allergy in Children
• Intervention / Treatment: Other: None - Cross Sectional.

Detailed Description

Preventing food allergic reactions predominantly relies on allergen avoidance and managing this daily causes high anxiety in some patients, while having an allergic reaction can cause a post-traumatic stress disorder-like syndrome in children. The underlying mechanisms of these psychological changes are poorly understood, but one potential mechanism may be post-natal hippocampal neurogenesis (HN). HN is the production of new neurons from stem cells in the hippocampus which is one of the brain centres for memory and mood regulation. HN has been associated with cognitive function and some psychiatric disorders. Importantly, it can be influenced by both internal (bloodstream) and external (exercise, diet, etc.) factors. This study will explore the link between food allergy and children's mental health and cognition, and to determine whether this is linked to changes in HN.

This study will recruit child patients (aged 8-15 years), and their legal parent/guardian, that are attending a routine clinic appointment at the Paediatric Allergy Unit at St Thomas' Hospital. Parent/guardians and the child will be approached by the patient's direct clinical team, who will explain the study procedures involved in participation. Consented adult (parent/guardian) participants will be asked to complete three anxiety questionnaires, to assess the influence of parental anxiety on that of the child. Consented child participants will be asked to complete two anxiety questionnaires and a memory task. Blood samples from the patient will also be collected in addition to those taken as part of their routine clinic appointment. Specifically, blood will be collected in the following tubes: gold top Vacutainer tube containing clot activator and gel for serum separation (4ml 8-15yrs), green top Vacutainer tube containing lithium heparin for whole blood (4ml 8-15yrs), and blue top Vacutainer tube containing citrate for peripheral blood mononuclear cell (PBMC) and plasma separation and storage (30ml 8-12yrs; 50ml 13-15yrs).

The plasma and serum from this collection will be used on two stem cell models that mimic food allergic reactions and HN, respectively. Any differences in these processes will be analysed alongside the questionnaire and memory task data and, if a link is successfully demonstrated, further work will aim to identify blood-borne factors responsible for these changes. This study will shed light on the impact of food allergy on children's mental health as well as the biological processes behind it.

• Study Type: Observational
• Enrollment (Estimated): 50

Contacts and Locations

• Study Contact: Name: Alexandra Santos, PhD; Phone Number: +44 (0) 20 7188 6424; Email: alexandra.santos@kcl.ac.uk

Study Locations

• United Kingdom
  • London, United Kingdom, SE1 7EH
    • Recruiting
    • St Thomas Hospital
    • Contact: Alexandra Santos, PhD; Phone Number: +44 (0) 20 7188 6424; Email: alexandra.santos@kcl.ac.uk

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child
• Accepts Healthy Volunteers: No

• Sampling Method: Probability Sample

Study Population

This study will recruit child patients (aged 8-15 years), and their legal parent/guardian, that are attending a routine clinic appointment at the Paediatric Allergy Unit at St Thomas' Hospital.

Description

Inclusion Criteria:

• • Children ≥ 8 years old and <16 years

  • Suspected food allergy (non-defined allergen)
  • Undergoing blood collection for IgE testing at their clinic appointment
  • Fluent / age-appropriate level of English (verbal and written) of both the child and legal parent / guardian

Exclusion Criteria:

• Diagnosed neurological disorders and learning disabilities, including autism spectrum disorder, attention deficit hyperactivity disorder, Down's Syndrome.

  • Undergoing any allergen-specific immunotherapy or other immunomodulatory treatments such as biologics and immunosuppressants

Study Plan

How is the study designed?

Number of groups / cohorts

3

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Non Allergic; Recruited patients whose medical records indicate they are not allergic to the foods they were in clinic for	Other: None - Cross Sectional.; There is no intervention, this is cross-sectional only.
Mild Allergic; Recruited patients whose medical records indicate they are allergic to the foods they were in clinic for, but only to a mild degree where they would be expected to experience mild, non-life threatening symptoms on exposure to the allergen	Other: None - Cross Sectional.; There is no intervention, this is cross-sectional only.
Severe Allergic; Recruited patients whose medical records indicate they are allergic to the foods they were in clinic for, to a severe degree where they would be expected to experience severe symptoms on exposure to the allergen	Other: None - Cross Sectional.; There is no intervention, this is cross-sectional only.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of DAPI-positive cells by allergic group	After exposure to patient serum, the number of DAPI-positive cells will be measured in the in vitro assay will be measured	Throughout study, on average 2.5 years
%Ki67-positive cells by allergic group	After exposure to patient serum, cells fluorescently expressing Ki67 will be quantified within a total pool of cells that are fluorescently positive for DAPI (a nuclear DNA stain), i.e., total percentage of double fluorescently labelled cells within a total single (DAPI) stained population.	Throughout study, on average 2.5 years
%CC3-positive cells by allergic group	After exposure to patient serum, cells fluorescently expressing CC3 will be quantified within a total pool of cells that are fluorescently positive for DAPI (a nuclear DNA stain), i.e., total percentage of double fluorescently labelled cells within a total single (DAPI) stained population.	Throughout study, on average 2.5 years
%Nestin-positive cells by allergic group	After exposure to patient serum, cells fluorescently expressing Nestin will be quantified within a total pool of cells that are fluorescently positive for DAPI (a nuclear DNA stain), i.e., total percentage of double fluorescently labelled cells within a total single (DAPI) stained population.	Throughout study, on average 2.5 years
%SOX2-positive cells by allergic group	After exposure to patient serum, cells fluorescently expressing SOX2 will be quantified within a total pool of cells that are fluorescently positive for DAPI (a nuclear DNA stain), i.e., total percentage of double fluorescently labelled cells within a total single (DAPI) stained population.	Throughout study, on average 2.5 years
%MAP2-positive cells by allergic group	After exposure to patient serum, cells fluorescently expressing MAP2 will be quantified within a total pool of cells that are fluorescently positive for DAPI (a nuclear DNA stain), i.e., total percentage of double fluorescently labelled cells within a total single (DAPI) stained population.	Throughout study, on average 2.5 years
%DCX-positive cells by allergic group	After exposure to patient serum, cells fluorescently expressing DCX will be quantified within a total pool of cells that are fluorescently positive for DAPI (a nuclear DNA stain), i.e., total percentage of double fluorescently labelled cells within a total single (DAPI) stained population.	Throughout study, on average 2.5 years

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
General anxiety levels of children by their allergic status, using the Spence's Children's Anxiety Scale	To determine whether food allergy is associated with changes to general anxiety in children. General anxiety levels will be assessed using the Spence's Children's Anxiety Scale, which has a minimum value of 0 and a maximum value of 114, with higher scores indicating higher levels of anxiety. Mean anxiety scores will be compared across allergic groups.	Throughout study, on average 2.5 years
General anxiety levels of parents by their child's allergic status, using the Hospital Anxiety Depression Scale	To determine whether food allergy is associated with changes to general anxiety in the legal caregiver. General anxiety levels will be assessed using the Hospital Anxiety Depression Scale, which has a minimum limit of 0 and a maximum limit of 21 for anxiety, with a higher score representing higher levels of anxiety. Mean anxiety scores will be compared across allergic groups. Mean anxiety scores will be compared across allergic groups.	Throughout study, on average 2.5 years
Food allergy-specific anxiety levels of children by their allergic status, using the Worry About Food Allergy scale	To determine whether food allergy is associated with changes to food allergy-specific anxiety in children. Food allergy-specific anxiety levels in children will be assessed using the Worry About Food Allergy Child (8-12yrs) and Teen scales (13+yrs). The 8-12yrs variant has a minimum score of 0 and a maximum score of 80. The 13+yrs variant has a minimum score of 0 and a maximum score of 88. Mean anxiety scores will be compared across allergic groups.	Throughout study, on average 2.5 years
Food-allergy specific anxiety levels of parents by their child's allergic status, using the Worry About Food Allergy scale	To determine whether food allergy is associated with changes to food allergy-specific anxiety in the legal caregiver. Food allergy-specific anxiety levels in parents will be assessed using the Worry About Food Allergy Parent scale, which has two variants based on age: one for parents of children aged 8-12yrs and one for parents of children aged 13+yrs. The 8-12yrs variant has a minimum score of 0 and a maximum score of 96. The 13+yrs variant has a minimum score of 0 and a maximum score of 108. Mean anxiety scores will be compared across allergic groups.	Throughout study, on average 2.5 years
Cognitive performance by allergic status, using the Mnemonic Similarity Task	To determine whether food allergy is associated with changes to cognition in children. Cognition will be measured using the Mnemonic Similarity Task, which assesses a specific form of memory called pattern separation. In this task, participants are assessed on their ability to distinguish 'lure' images (images that are similar but different to images seen in the initial phase) from 'old' images (images that are exactly the same as seen in the initial phase). This ability is recorded as the "Lure Discrimination Index", given on a scale of 0-1, with a higher score indicating great cognitive performance.	Throughout study, on average 2.5 years
General anxiety levels by hippocampal neurogenic dynamics	To determine whether any observed food allergy-induced changes to hippocampal neurogenesis are linked to changes in general anxiety, as measured by the correlation between mean percentage expression of neurogenic readouts (outlined in Outcomes 1-7) and general anxiety scores (outlined in Outcome 2)	Throughout study, on average 2.5 years
Food allergy-specific anxiety by hippocampal neurogenic dynamics	To determine whether any observed food allergy-induced changes to hippocampal neurogenesis are linked to changes in food allergy-specific anxiety, as measured by the correlation between mean percentage expression of neurogenic readouts (outlined in Outcomes 1-7) and food allergy-specific anxiety scores (outlined in Outcome 4).	Throughout study, on average 2.5 years
Cognitive performance by hippocampal neurogenic dynamics	To determine whether any observed food allergy-induced changes to hippocampal neurogenesis are linked to changes in cognitive function, as measured by the correlation between mean percentage expression of neurogenic readouts (outlined in Outcomes 1-7) and cognition scores (outline in Outcome 6)	Throughout study, on average 2.5 years
The association between food allergy diagnosis and Mast Cell Activation (MAT)	To assess the association between food allergy diagnosis and MAT to specific allergen in this cohort, as measured by mean %CD63 activation of LAD2 mast cells between allergic groups. A higher percentage of %CD63 activation of LAD2 cells indicate a higher allergic response	Throughout study, on average 2.5 years
The association between the Mast Cell Activation (MAT) and hippocampal neurogenesis	Correlation between %CD63 activation with neurogenesis (Outcomes 1-7)	Throughout study, on average 2.5 years
The association between hippocampal neurogenesis and general anxiety levels	Correlation between neurogenesis rates (outcomes 1-7) and general anxiety scores (outcome 2)	Throughout study, on average 2.5 years
The association between hippocampal neurogenesis and food allergy-specific anxiety levels	Correlation between neurogenesis rates (outcomes 1-7) and food allergy-specific anxiety scores (outcome 4)	Throughout study, on average 2.5 years
The association between hippocampal neurogenesis and cognitive performance	Correlation between neurogenesis rates (outcomes 1-7) and cognitive scores (outcome 6)	Throughout study, on average 2.5 years
The association between hippocampal neurogenesis and food allergy medical history	To assess the effect of multiple food allergy diagnoses (reported as a number indicated number of other food allergy diagnoses) on hippocampal neurogenesis (outcomes 1-7)	Throughout study, on average 2.5 years
The association between hippocampal neurogenesis and atopic disease diagnoses	To assess the effect of atopic disease diagnoses (reported as a number indicated number of atopic disease diagnoses) on hippocampal neurogenesis ((outcomes 1-7)	Throughout study, on average 2.5 years

Collaborators and Investigators

• Sponsor: King's College London
• Collaborators: Guy's and St Thomas' NHS Foundation Trust

Study record dates

Study Major Dates

• Study Start (Actual): September 29, 2023
• Primary Completion (Estimated): September 30, 2025
• Study Completion (Estimated): October 1, 2025

Study Registration Dates

• First Submitted: February 27, 2023
• First Submitted That Met QC Criteria: April 20, 2023
• First Posted (Actual): May 3, 2023

Study Record Updates

• Last Update Posted (Estimated): November 13, 2023
• Last Update Submitted That Met QC Criteria: November 9, 2023
• Last Verified: February 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Nervous System Diseases; Immune System Diseases; Hypersensitivity, Immediate; Neurologic Manifestations; Hypersensitivity; Neurobehavioral Manifestations; Food Hypersensitivity
• Other Study ID Numbers: 322589

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: There is no plan to share IPD

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No